Your browser doesn't support javascript.
loading
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination.
Baker, David; Forte, Eugenia; Pryce, Gareth; Kang, Angray S; James, Louisa K; Giovannoni, Gavin; Schmierer, Klaus.
Afiliación
  • Baker D; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom. Electronic address: david.baker@qmul.ac.uk.
  • Forte E; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
  • Pryce G; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
  • Kang AS; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom; Centre for Oral Immunobiology and Regenerative Medicine, Dental Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • James LK; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
  • Giovannoni G; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Schmierer K; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Mult Scler Relat Disord ; 69: 104425, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36470168
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Moduladores de los Receptores de fosfatos y esfingosina 1 / COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Moduladores de los Receptores de fosfatos y esfingosina 1 / COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article